Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Sickle Cell Disease
NCT01800526Phase 2Completed
- Sponsor
- Bloodworks Northwest
- Start
- Mar 2013
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in sickle cell disease (SCD), sponsored by Bloodworks Northwest. Started Mar 2013; status: completed.
02
Drugs
acetylcysteine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01800526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800526.